{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:36:07Z","timestamp":1768448167340,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.bmcl.2010.12.116","type":"journal-article","created":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T04:23:46Z","timestamp":1294460626000},"page":"2641-2645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists"],"prefix":"10.1016","volume":"21","author":[{"given":"David A.","family":"Griffith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane M.","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"De Lombaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Inthavongsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee E.","family":"Klade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin R.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Carpino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2010.12.116_b0005","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jama.291.10.1238","volume":"291","author":"Mikdad","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bmcl.2010.12.116_b0010","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2174\/138955709788452739","volume":"9","author":"Isidro","year":"2009","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.bmcl.2010.12.116_b0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/193229680800200525","volume":"2","author":"Klonoff","year":"2008","journal-title":"Diabetes Sci. Technol."},{"key":"10.1016\/j.bmcl.2010.12.116_b0020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2007-0003","volume":"28","author":"Kamiji","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bmcl.2010.12.116_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1054\/npep.2002.0897","volume":"36","author":"Thorsell","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bmcl.2010.12.116_b0030","first-page":"1986","volume":"7","author":"Stanley","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/j.bmcl.2010.12.116_b0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/13543784.9.6.1327","volume":"9","author":"Wieland","year":"2000","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bmcl.2010.12.116_b0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0166-2236(96)01057-0","volume":"20","author":"Blomqvist","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bmcl.2010.12.116_b0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.npep.2004.05.009","volume":"38","author":"Fetissov","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.bmcl.2010.12.116_b0050","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/oby.2007.620","volume":"15","author":"Erondu","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.bmcl.2010.12.116_b0065","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1016\/j.bmcl.2009.09.048","volume":"19","author":"Sun","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2010.12.116_b0070","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1016\/j.bmcl.2009.06.050","volume":"19","author":"Cho","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2010.12.116_b0075","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1016\/j.bmcl.2009.05.069","volume":"19","author":"Kameda","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2010.12.116_b0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/156802609788897853","volume":"9","author":"Lee","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2010.12.116_b0090","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2174\/156802607782341028","volume":"7","author":"MacNeil","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bmcl.2010.12.116_b0105","unstructured":"ElogD was calculated from a model built according to the methods described in Ref. 15b, based on Cubist [Rulequest Research, www.rulequest.com]. The training set for the model was 33,000 ElogD values measured using methodology described in Ref. 15c."},{"key":"10.1016\/j.bmcl.2010.12.116_b0110","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1124\/dmd.107.020131","volume":"36","author":"Gao","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bmcl.2010.12.116_b0115","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jm0100990","volume":"44","author":"Lombardo","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2010.12.116_b0140","first-page":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bmcl.2010.12.116_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/bdd.325","volume":"23","author":"Kalvass","year":"2002","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.bmcl.2010.12.116_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"Schinkel","year":"1999","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.bmcl.2010.12.116_b0175","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cmdc.200700059","volume":"2","author":"Morgenthaler","year":"2007","journal-title":"ChemMedChem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X10018809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X10018809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T06:23:17Z","timestamp":1760768597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X10018809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0960894X10018809"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2010.12.116","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonists","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2010.12.116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}